img

Global Erectile Dysfunction Medication Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Erectile Dysfunction Medication Market Insights, Forecast to 2034

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Market Analysis and InsightsGlobal Erectile Dysfunction Medication Market
The global Erectile Dysfunction Medication market is projected to grow from US$ 5059.3 million in 2024 to US$ 6277.1 million by 2034, at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Includes
This report presents an overview of global market for Erectile Dysfunction Medication market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Erectile Dysfunction Medication, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Erectile Dysfunction Medication, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Erectile Dysfunction Medication revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Erectile Dysfunction Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Erectile Dysfunction Medication revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Bayer, Lilly, Guangzhou Baiyunshan, Qilu Pharmaceutical, Yabang Pharmacy, Hebei Changshan Biochemical, Diao and Guangzhou Hairui Pharmaceutical, etc.



By Company


Pfizer
Bayer
Lilly
Guangzhou Baiyunshan
Qilu Pharmaceutical
Yabang Pharmacy
Hebei Changshan Biochemical
Diao
Guangzhou Hairui Pharmaceutical
Chiatai Tianqing
Jiangsu Tasly
Chongqing Huapont
Humanwell
Segment by Type
Viagra
Levitra
Cialis
Stendra

Segment by Application


Pharmacies
Medical Institutions
Pharmaceutical E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Erectile Dysfunction Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Erectile Dysfunction Medication companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erectile Dysfunction Medication revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erectile Dysfunction Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Viagra
1.2.3 Levitra
1.2.4 Cialis
1.2.5 Stendra
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pharmacies
1.3.3 Medical Institutions
1.3.4 Pharmaceutical E-commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erectile Dysfunction Medication Market Perspective (2018-2034)
2.2 Global Erectile Dysfunction Medication Growth Trends by Region
2.2.1 Erectile Dysfunction Medication Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Erectile Dysfunction Medication Historic Market Size by Region (2018-2024)
2.2.3 Erectile Dysfunction Medication Forecasted Market Size by Region (2024-2034)
2.3 Erectile Dysfunction Medication Market Dynamics
2.3.1 Erectile Dysfunction Medication Industry Trends
2.3.2 Erectile Dysfunction Medication Market Drivers
2.3.3 Erectile Dysfunction Medication Market Challenges
2.3.4 Erectile Dysfunction Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Erectile Dysfunction Medication by Players
3.1.1 Global Erectile Dysfunction Medication Revenue by Players (2018-2024)
3.1.2 Global Erectile Dysfunction Medication Revenue Market Share by Players (2018-2024)
3.2 Global Erectile Dysfunction Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Erectile Dysfunction Medication, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Erectile Dysfunction Medication Market Concentration Ratio
3.4.1 Global Erectile Dysfunction Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Medication Revenue in 2022
3.5 Global Key Players of Erectile Dysfunction Medication Head office and Area Served
3.6 Global Key Players of Erectile Dysfunction Medication, Product and Application
3.7 Global Key Players of Erectile Dysfunction Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Erectile Dysfunction Medication Breakdown Data by Type
4.1 Global Erectile Dysfunction Medication Historic Market Size by Type (2018-2024)
4.2 Global Erectile Dysfunction Medication Forecasted Market Size by Type (2024-2034)
5 Erectile Dysfunction Medication Breakdown Data by Application
5.1 Global Erectile Dysfunction Medication Historic Market Size by Application (2018-2024)
5.2 Global Erectile Dysfunction Medication Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Erectile Dysfunction Medication Market Size (2018-2034)
6.2 North America Erectile Dysfunction Medication Market Size by Type
6.2.1 North America Erectile Dysfunction Medication Market Size by Type (2018-2024)
6.2.2 North America Erectile Dysfunction Medication Market Size by Type (2024-2034)
6.2.3 North America Erectile Dysfunction Medication Market Share by Type (2018-2034)
6.3 North America Erectile Dysfunction Medication Market Size by Application
6.3.1 North America Erectile Dysfunction Medication Market Size by Application (2018-2024)
6.3.2 North America Erectile Dysfunction Medication Market Size by Application (2024-2034)
6.3.3 North America Erectile Dysfunction Medication Market Share by Application (2018-2034)
6.4 North America Erectile Dysfunction Medication Market Size by Country
6.4.1 North America Erectile Dysfunction Medication Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Erectile Dysfunction Medication Market Size by Country (2018-2024)
6.4.3 North America Erectile Dysfunction Medication Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Erectile Dysfunction Medication Market Size (2018-2034)
7.2 Europe Erectile Dysfunction Medication Market Size by Type
7.2.1 Europe Erectile Dysfunction Medication Market Size by Type (2018-2024)
7.2.2 Europe Erectile Dysfunction Medication Market Size by Type (2024-2034)
7.2.3 Europe Erectile Dysfunction Medication Market Share by Type (2018-2034)
7.3 Europe Erectile Dysfunction Medication Market Size by Application
7.3.1 Europe Erectile Dysfunction Medication Market Size by Application (2018-2024)
7.3.2 Europe Erectile Dysfunction Medication Market Size by Application (2024-2034)
7.3.3 Europe Erectile Dysfunction Medication Market Share by Application (2018-2034)
7.4 Europe Erectile Dysfunction Medication Market Size by Country
7.4.1 Europe Erectile Dysfunction Medication Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Erectile Dysfunction Medication Market Size by Country (2018-2024)
7.4.3 Europe Erectile Dysfunction Medication Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Erectile Dysfunction Medication Market Size (2018-2034)
8.2 China Erectile Dysfunction Medication Market Size by Type
8.2.1 China Erectile Dysfunction Medication Market Size by Type (2018-2024)
8.2.2 China Erectile Dysfunction Medication Market Size by Type (2024-2034)
8.2.3 China Erectile Dysfunction Medication Market Share by Type (2018-2034)
8.3 China Erectile Dysfunction Medication Market Size by Application
8.3.1 China Erectile Dysfunction Medication Market Size by Application (2018-2024)
8.3.2 China Erectile Dysfunction Medication Market Size by Application (2024-2034)
8.3.3 China Erectile Dysfunction Medication Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Erectile Dysfunction Medication Market Size (2018-2034)
9.2 Asia Erectile Dysfunction Medication Market Size by Type
9.2.1 Asia Erectile Dysfunction Medication Market Size by Type (2018-2024)
9.2.2 Asia Erectile Dysfunction Medication Market Size by Type (2024-2034)
9.2.3 Asia Erectile Dysfunction Medication Market Share by Type (2018-2034)
9.3 Asia Erectile Dysfunction Medication Market Size by Application
9.3.1 Asia Erectile Dysfunction Medication Market Size by Application (2018-2024)
9.3.2 Asia Erectile Dysfunction Medication Market Size by Application (2024-2034)
9.3.3 Asia Erectile Dysfunction Medication Market Share by Application (2018-2034)
9.4 Asia Erectile Dysfunction Medication Market Size by Region
9.4.1 Asia Erectile Dysfunction Medication Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Erectile Dysfunction Medication Market Size by Region (2018-2024)
9.4.3 Asia Erectile Dysfunction Medication Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Erectile Dysfunction Medication Introduction
11.1.4 Pfizer Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Erectile Dysfunction Medication Introduction
11.2.4 Bayer Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.2.5 Bayer Recent Developments
11.3 Lilly
11.3.1 Lilly Company Details
11.3.2 Lilly Business Overview
11.3.3 Lilly Erectile Dysfunction Medication Introduction
11.3.4 Lilly Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.3.5 Lilly Recent Developments
11.4 Guangzhou Baiyunshan
11.4.1 Guangzhou Baiyunshan Company Details
11.4.2 Guangzhou Baiyunshan Business Overview
11.4.3 Guangzhou Baiyunshan Erectile Dysfunction Medication Introduction
11.4.4 Guangzhou Baiyunshan Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.4.5 Guangzhou Baiyunshan Recent Developments
11.5 Qilu Pharmaceutical
11.5.1 Qilu Pharmaceutical Company Details
11.5.2 Qilu Pharmaceutical Business Overview
11.5.3 Qilu Pharmaceutical Erectile Dysfunction Medication Introduction
11.5.4 Qilu Pharmaceutical Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.5.5 Qilu Pharmaceutical Recent Developments
11.6 Yabang Pharmacy
11.6.1 Yabang Pharmacy Company Details
11.6.2 Yabang Pharmacy Business Overview
11.6.3 Yabang Pharmacy Erectile Dysfunction Medication Introduction
11.6.4 Yabang Pharmacy Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.6.5 Yabang Pharmacy Recent Developments
11.7 Hebei Changshan Biochemical
11.7.1 Hebei Changshan Biochemical Company Details
11.7.2 Hebei Changshan Biochemical Business Overview
11.7.3 Hebei Changshan Biochemical Erectile Dysfunction Medication Introduction
11.7.4 Hebei Changshan Biochemical Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.7.5 Hebei Changshan Biochemical Recent Developments
11.8 Diao
11.8.1 Diao Company Details
11.8.2 Diao Business Overview
11.8.3 Diao Erectile Dysfunction Medication Introduction
11.8.4 Diao Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.8.5 Diao Recent Developments
11.9 Guangzhou Hairui Pharmaceutical
11.9.1 Guangzhou Hairui Pharmaceutical Company Details
11.9.2 Guangzhou Hairui Pharmaceutical Business Overview
11.9.3 Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Introduction
11.9.4 Guangzhou Hairui Pharmaceutical Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.9.5 Guangzhou Hairui Pharmaceutical Recent Developments
11.10 Chiatai Tianqing
11.10.1 Chiatai Tianqing Company Details
11.10.2 Chiatai Tianqing Business Overview
11.10.3 Chiatai Tianqing Erectile Dysfunction Medication Introduction
11.10.4 Chiatai Tianqing Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.10.5 Chiatai Tianqing Recent Developments
11.11 Jiangsu Tasly
11.11.1 Jiangsu Tasly Company Details
11.11.2 Jiangsu Tasly Business Overview
11.11.3 Jiangsu Tasly Erectile Dysfunction Medication Introduction
11.11.4 Jiangsu Tasly Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.11.5 Jiangsu Tasly Recent Developments
11.12 Chongqing Huapont
11.12.1 Chongqing Huapont Company Details
11.12.2 Chongqing Huapont Business Overview
11.12.3 Chongqing Huapont Erectile Dysfunction Medication Introduction
11.12.4 Chongqing Huapont Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.12.5 Chongqing Huapont Recent Developments
11.13 Humanwell
11.13.1 Humanwell Company Details
11.13.2 Humanwell Business Overview
11.13.3 Humanwell Erectile Dysfunction Medication Introduction
11.13.4 Humanwell Revenue in Erectile Dysfunction Medication Business (2018-2024)
11.13.5 Humanwell Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Erectile Dysfunction Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Viagra
Table 3. Key Players of Levitra
Table 4. Key Players of Cialis
Table 5. Key Players of Stendra
Table 6. Global Erectile Dysfunction Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Erectile Dysfunction Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Erectile Dysfunction Medication Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Erectile Dysfunction Medication Market Share by Region (2018-2024)
Table 10. Global Erectile Dysfunction Medication Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Erectile Dysfunction Medication Market Share by Region (2024-2034)
Table 12. Erectile Dysfunction Medication Market Trends
Table 13. Erectile Dysfunction Medication Market Drivers
Table 14. Erectile Dysfunction Medication Market Challenges
Table 15. Erectile Dysfunction Medication Market Restraints
Table 16. Global Erectile Dysfunction Medication Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Erectile Dysfunction Medication Revenue Share by Players (2018-2024)
Table 18. Global Top Erectile Dysfunction Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Medication as of 2022)
Table 19. Global Erectile Dysfunction Medication Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Erectile Dysfunction Medication Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Erectile Dysfunction Medication, Headquarters and Area Served
Table 22. Global Key Players of Erectile Dysfunction Medication, Product and Application
Table 23. Global Key Players of Erectile Dysfunction Medication, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Erectile Dysfunction Medication Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Erectile Dysfunction Medication Revenue Market Share by Type (2018-2024)
Table 27. Global Erectile Dysfunction Medication Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Erectile Dysfunction Medication Revenue Market Share by Type (2024-2034)
Table 29. Global Erectile Dysfunction Medication Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Erectile Dysfunction Medication Revenue Share by Application (2018-2024)
Table 31. Global Erectile Dysfunction Medication Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Erectile Dysfunction Medication Revenue Share by Application (2024-2034)
Table 33. North America Erectile Dysfunction Medication Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Erectile Dysfunction Medication Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America Erectile Dysfunction Medication Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Erectile Dysfunction Medication Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America Erectile Dysfunction Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America Erectile Dysfunction Medication Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Erectile Dysfunction Medication Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Erectile Dysfunction Medication Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Erectile Dysfunction Medication Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe Erectile Dysfunction Medication Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Erectile Dysfunction Medication Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe Erectile Dysfunction Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe Erectile Dysfunction Medication Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Erectile Dysfunction Medication Market Size by Country (2024-2034) & (US$ Million)
Table 47. China Erectile Dysfunction Medication Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Erectile Dysfunction Medication Market Size by Type (2024-2034) & (US$ Million)
Table 49. China Erectile Dysfunction Medication Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Erectile Dysfunction Medication Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia Erectile Dysfunction Medication Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Erectile Dysfunction Medication Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia Erectile Dysfunction Medication Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Erectile Dysfunction Medication Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Erectile Dysfunction Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Erectile Dysfunction Medication Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Erectile Dysfunction Medication Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Erectile Dysfunction Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size by Country (2024-2034) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Erectile Dysfunction Medication Product
Table 68. Pfizer Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Bayer Company Details
Table 71. Bayer Business Overview
Table 72. Bayer Erectile Dysfunction Medication Product
Table 73. Bayer Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 74. Bayer Recent Developments
Table 75. Lilly Company Details
Table 76. Lilly Business Overview
Table 77. Lilly Erectile Dysfunction Medication Product
Table 78. Lilly Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 79. Lilly Recent Developments
Table 80. Guangzhou Baiyunshan Company Details
Table 81. Guangzhou Baiyunshan Business Overview
Table 82. Guangzhou Baiyunshan Erectile Dysfunction Medication Product
Table 83. Guangzhou Baiyunshan Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 84. Guangzhou Baiyunshan Recent Developments
Table 85. Qilu Pharmaceutical Company Details
Table 86. Qilu Pharmaceutical Business Overview
Table 87. Qilu Pharmaceutical Erectile Dysfunction Medication Product
Table 88. Qilu Pharmaceutical Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 89. Qilu Pharmaceutical Recent Developments
Table 90. Yabang Pharmacy Company Details
Table 91. Yabang Pharmacy Business Overview
Table 92. Yabang Pharmacy Erectile Dysfunction Medication Product
Table 93. Yabang Pharmacy Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 94. Yabang Pharmacy Recent Developments
Table 95. Hebei Changshan Biochemical Company Details
Table 96. Hebei Changshan Biochemical Business Overview
Table 97. Hebei Changshan Biochemical Erectile Dysfunction Medication Product
Table 98. Hebei Changshan Biochemical Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 99. Hebei Changshan Biochemical Recent Developments
Table 100. Diao Company Details
Table 101. Diao Business Overview
Table 102. Diao Erectile Dysfunction Medication Product
Table 103. Diao Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 104. Diao Recent Developments
Table 105. Guangzhou Hairui Pharmaceutical Company Details
Table 106. Guangzhou Hairui Pharmaceutical Business Overview
Table 107. Guangzhou Hairui Pharmaceutical Erectile Dysfunction Medication Product
Table 108. Guangzhou Hairui Pharmaceutical Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 109. Guangzhou Hairui Pharmaceutical Recent Developments
Table 110. Chiatai Tianqing Company Details
Table 111. Chiatai Tianqing Business Overview
Table 112. Chiatai Tianqing Erectile Dysfunction Medication Product
Table 113. Chiatai Tianqing Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 114. Chiatai Tianqing Recent Developments
Table 115. Jiangsu Tasly Company Details
Table 116. Jiangsu Tasly Business Overview
Table 117. Jiangsu Tasly Erectile Dysfunction Medication Product
Table 118. Jiangsu Tasly Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 119. Jiangsu Tasly Recent Developments
Table 120. Chongqing Huapont Company Details
Table 121. Chongqing Huapont Business Overview
Table 122. Chongqing Huapont Erectile Dysfunction Medication Product
Table 123. Chongqing Huapont Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 124. Chongqing Huapont Recent Developments
Table 125. Humanwell Company Details
Table 126. Humanwell Business Overview
Table 127. Humanwell Erectile Dysfunction Medication Product
Table 128. Humanwell Revenue in Erectile Dysfunction Medication Business (2018-2024) & (US$ Million)
Table 129. Humanwell Recent Developments
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erectile Dysfunction Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Erectile Dysfunction Medication Market Share by Type: 2022 VS 2034
Figure 3. Viagra Features
Figure 4. Levitra Features
Figure 5. Cialis Features
Figure 6. Stendra Features
Figure 7. Global Erectile Dysfunction Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Erectile Dysfunction Medication Market Share by Application: 2022 VS 2034
Figure 9. Pharmacies Case Studies
Figure 10. Medical Institutions Case Studies
Figure 11. Pharmaceutical E-commerce Case Studies
Figure 12. Erectile Dysfunction Medication Report Years Considered
Figure 13. Global Erectile Dysfunction Medication Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Erectile Dysfunction Medication Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Erectile Dysfunction Medication Market Share by Region: 2022 VS 2034
Figure 16. Global Erectile Dysfunction Medication Market Share by Players in 2022
Figure 17. Global Top Erectile Dysfunction Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Medication as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Erectile Dysfunction Medication Revenue in 2022
Figure 19. North America Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Erectile Dysfunction Medication Market Share by Type (2018-2034)
Figure 21. North America Erectile Dysfunction Medication Market Share by Application (2018-2034)
Figure 22. North America Erectile Dysfunction Medication Market Share by Country (2018-2034)
Figure 23. United States Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Erectile Dysfunction Medication Market Size YoY (2018-2034) & (US$ Million)
Figure 26. Europe Erectile Dysfunction Medication Market Share by Type (2018-2034)
Figure 27. Europe Erectile Dysfunction Medication Market Share by Application (2018-2034)
Figure 28. Europe Erectile Dysfunction Medication Market Share by Country (2018-2034)
Figure 29. Germany Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. France Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. U.K. Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Italy Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Russia Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Nordic Countries Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. China Erectile Dysfunction Medication Market Size YoY (2018-2034) & (US$ Million)
Figure 36. China Erectile Dysfunction Medication Market Share by Type (2018-2034)
Figure 37. China Erectile Dysfunction Medication Market Share by Application (2018-2034)
Figure 38. Asia Erectile Dysfunction Medication Market Size YoY (2018-2034) & (US$ Million)
Figure 39. Asia Erectile Dysfunction Medication Market Share by Type (2018-2034)
Figure 40. Asia Erectile Dysfunction Medication Market Share by Application (2018-2034)
Figure 41. Asia Erectile Dysfunction Medication Market Share by Region (2018-2034)
Figure 42. Japan Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. South Korea Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. China Taiwan Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Southeast Asia Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. India Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Australia Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Size YoY (2018-2034) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Share by Type (2018-2034)
Figure 50. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Share by Application (2018-2034)
Figure 51. Middle East, Africa, and Latin America Erectile Dysfunction Medication Market Share by Country (2018-2034)
Figure 52. Brazil Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Mexico Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Turkey Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Israel Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. GCC Countries Erectile Dysfunction Medication Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 60. Lilly Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 61. Guangzhou Baiyunshan Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 62. Qilu Pharmaceutical Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 63. Yabang Pharmacy Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 64. Hebei Changshan Biochemical Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 65. Diao Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 66. Guangzhou Hairui Pharmaceutical Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 67. Chiatai Tianqing Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 68. Jiangsu Tasly Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 69. Chongqing Huapont Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 70. Humanwell Revenue Growth Rate in Erectile Dysfunction Medication Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries